CDNA
CareDx·NASDAQ
--
--(--)
--
--(--)
7.38 / 10
Outperform
Analyst sentiment is upbeat (7.38/10) with one Strong Buy and one Neutral, yielding a weighted rating of 6.80. Fund flow is strong (7.96/10) across all size categories, showing positive inflows. Despite a 4.14% price drop, outlook remains favorable.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-25
InstitutionWells Fargo
Times predicted3
Historical Win Rate66.7%
What is the analyst consensus for CDNA?
- CDNA holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.38/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
